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INTRODUCTION & OBJECTIVES: This study reports a multicentric international prospective dataset of NSS performed in cT1b renal
tumors. The aim of this study is to analyse the predictive factors of surgical complications, longer ischemia time and trifecta outcome for
renal masses greater than 4 cm.
MATERIAL & METHODS: 248 cases of NSS in cT1b renal tumors performed in 23 centres were prospectively analysed. Patients were
treated in low and high volume centres (defined as < or ≥ 50 per year NSS). Trifecta was defined as simultaneous ischemia < 25 min, no
surgical complication and negative surgical margin. A descriptive analysis was carried out. A univariate analysis and multivariate logistic
regression were performed for surgical postoperative complications, Clavien 3 surgical complications, ischemia time > 25 min and Trifecta.
RESULTS: A median clinical tumor diameter of 5 (4.5-5.5) cm was reported. 37.5% lesions presented  a <50% exophytic growth pattern
and 37.5% lesions were in mid kidney. 17.7% cases were performed in low volume centres. Overall, 60.1% cases were performed using a
minimally invasive approach. A clampless technique was used in 18.5% of cases. Ischemia time presented a median of 20 (16-25) minutes
and 26.6% cases had a > 25 min ischemia time. Surgical complications were 18.1%, Clavien 2 were 9.3% and Clavien 3 were 4.8% of
cases. Positive surgical margin were registered 7.3% of patients. Trifecta was achieved 56% patients.
At uni and multivariate analysis mid kidney location (OR 1.96, p 0,05) and estimated blood loss (EBL) (OR 1.0, p 0.001) were predictive
factors of surgical complication. Mid kidney location (OR 4.2 p 0,03) and low volume centre (OR 5.1, p 0.02) were predictive of Clavien 3
surgical compications. At univariate analysis minimally invasive approach had significant > 25 min ischemia rate compared to open
standard approach (31.5% vs 19.2%, p 0.03), but it did not raise significance at multivariate analysis (OR 1.6 p 0.19). Also endophytic
growth pattern (OR 3.1, p<0.001) and EBL (OR 1.0, p<0.001) were predictive factors of > 25 min ischemia rate. Endophytic growth pattern
represents the only significant predictive factor of Trifecta (OR 1.29, p 0.004).
CONCLUSIONS: NSS seems a feasible technique for cT1b renal masses, but it still presents a high rate of surgical complications. Major
complications could be reduced by operating in highly experienced-centres. Surgical complications are mostly influenced by lesion site.
Endophytic growth pattern is the only predictive factor of Trifecta and higher ischemia time, which is also influenced by intraoperative
bleeding.
